Filing Summary
Business Context and Reporting Period
Steakholder Foods Ltd., an Israeli foreign private issuer, filed a Form 6-K covering August 2022. The filing was submitted on August 23, 2022, and reports the issuance of a press release concerning cultured pork research and development.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Developments
- The company announced a new induced pluripotent stem cell (iPS) porcine cell line for the development of cultured pork products.
- The announcement was included as Exhibit 99.1, a press release dated August 23, 2022.
Guidance, Outlook, Risks, and Unusual Items
The filing does not provide financial guidance, forecasts, management commentary on operating results, specific risks, contingencies, or details regarding the development timeline, commercialization prospects, or expected costs associated with the new cell line.
Facts Investors Should Verify
- The technical characteristics and performance of the new iPS porcine cell line.
- The stage of development and feasibility of using the cell line in cultured pork products.
- Expected regulatory, manufacturing, funding, and commercialization requirements.
- Any subsequent financial disclosures or updates concerning the program.